Eli Lilly is a pharmaceutical company that develops and sells medicines for diabetes, obesity, cancer, and other conditions. It last closed at $1415.43 on Nov 17, down 1.13% on the day. LLY reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 15 analysts is $1539.20 (+8.7% from the last close), with a high of $1700.00 and a low of $1250.00. Analyst consensus is Strong Buy, based on the latest ratings from 15 firms (15 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 44 whale options trades in LLY, 50% of them bullish and 50% bearish. In the past 30 days there were 146 dark pool prints totaling $185.3M, the largest $38.2M.
Each firm's latest rating on LLY in the past 90 days
Average 12-month target
$1539.20
▲ 8.7% upside
Based on 15 analysts who set a price target on LLY in the past 90 days. The average target is $1539.20, with a high of $1700.00 and a low of $1250.00, compared with the last close of $1415.43.
Highest target$1700.00
Average target$1539.20
Lowest target$1250.00
Latest rating changes
BarclaysMaintained
Nov 16Buy$1550
JefferiesTarget raised
Nov 9Buy$1350 → $1700
Cantor FitzgeraldTarget raised
Nov 2Buy$1440 → $1600
UBSTarget raised
Oct 31Buy$1425 → $1625
JP MorganTarget raised
Oct 30Buy$1500 → $1650
Date
Firm
Action
Rating
Price target
Nov 16
Barclays
Maintained
Buy
$1550
Nov 9
Jefferies
Target raised
Buy
$1350 → $1700
Nov 2
Cantor Fitzgerald
Target raised
Buy
$1440 → $1600
Oct 31
UBS
Target raised
Buy
$1425 → $1625
Oct 30
JP Morgan
Target raised
Buy
$1500 → $1650
Loading…
Technical Analysis
LLY · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 3% above its 20 day and 12% above its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 63), near overbought. The nearest support is the Pivot S1 at $1400.22, and the nearest resistance the Pivot at $1416.25.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityHigh, 3.1%/day
Key levels
$1475.2552 week high+4.2%
$1449.68Swing high (Oct 30)+2.4%
$1431.46Pivot R1+1.1%
$1416.25Pivot+0.1%
$1415.43Last close
$1400.22Pivot S1−1.1%
$1372.4020 day average−3.0%
$1333.22Swing low (Nov 6)−5.8%
$1252.5650 day average−11.5%
$1221.19100 day average−13.7%
$1113.15200 day average−21.4%
$850.5152 week low−39.9%
Indicators
RSI (14)
62.99
Strong, overbought above 70
Neutral
MACD
52.80
Below its signal line
Bearish
Stochastic
76.8
Middle of its range
Neutral
ADX (14)
38.0
Trending up
Williams %R
-41.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
50.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.4%
Change over 10 sessions
Bullish
ATR (14)
$43.60
Typical daily range, 3.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 6.3%/day
Key levels
$1475.2552 week high+4.2%
$1449.68Swing high (Oct 30)+2.4%
$1431.46Pivot R1+1.1%
$1416.25Pivot+0.1%
$1415.43Last close
$1400.22Pivot S1−1.1%
$1372.4020 day average−3.0%
$1333.22Swing low (Nov 6)−5.8%
$1252.5650 day average−11.5%
$1221.19100 day average−13.7%
$1113.15200 day average−21.4%
$850.5152 week low−39.9%
Indicators
RSI (14)
66.24
Strong, overbought above 70
Neutral
MACD
82.80
Above its signal line
Bullish
Stochastic
83.3
Near the top of its range
Overbought
ADX (14)
44.5
Strong uptrend
Williams %R
-16.5
Oversold below −80, overbought above −20
Overbought
CCI (20)
179.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+26.9%
Change over 10 sessions
Bullish
ATR (14)
$89.62
Typical daily range, 6.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for LLY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LLY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed22 bullish and 22 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow LLY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LLY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LLY is in one of them and how their past LLY trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About ELI LILLY &
Eli Lilly is a pharmaceutical company based in Indianapolis, Indiana. It discovers, develops, manufactures, and sells human medicines, with major products for diabetes and obesity, as well as treatments for cancer, immune conditions, migraine, and Alzheimer's disease. Its customers include wholesalers, pharmacies, hospitals, insurers, and healthcare providers, and it also sells directly to patients through its LillyDirect platform. Its products are sold in many countries around the world.